Menu
Home
Publishers
Categories
Trending
Inbox
Create Account
Sign in
Nederlands
Deutsch
Loading...
Fiercebiotech.com
Click on 'Go to the website!' to go to Fiercebiotech.com.
Button get active in
5
Continue to the website!
Loading...
Loading...
Other newsletters from Fiercebiotech.com
| 07.17.25 | GSK’s Blenrep g ets thumbs down from FDA pane l; As measles cases spike, treatment remains out of reach
Fiercebiotech.com
1752784915
| 07.17.25 | Sarepta sheds 500 staffers in efforts to save $400M; Novartis antibody misses in ph. 2 derm study
Fiercebiotech.com
1752768737
BREAKING: Sarepta kicks off reorg with 500 layoffs, R&D pivot
Fiercebiotech.com
1752700929
| 07.16.25 | FDA questions Lundbeck-Otsuka PTSD fil ing; AZ’s ph. 3 amyloidosis fail cuts to the marrow
Fiercebiotech.com
1752694929
E, learn how to turn passive visitors into active patients and HCPs
Fiercebiotech.com
1752688617
| 07.16.25 | AZ’s amyloidosis drug flunks ph. 3 trial; GSK plans ‘limit ed’ layoffs for R&D team
Fiercebiotech.com
1752682419
[White Paper] Alzheimer’s Disease: Early Interventions
Fiercebiotech.com
1752675086
| 07.15.25 | HHS issues pink slips, effective immediately; Sino buys Merck partner LaNova in $951M deal
Fiercebiotech.com
1752609476
How Software-Enhanced Drugs Are Shaping the Next Era of Patient Care
Fiercebiotech.com
1752607469
| 07.15.25 | Merck’s PD-1 bisp ecific partner scooped up in $ 951M deal; Hengrui hankers for GLP-1 approval after ph. 3 win
Fiercebiotech.com
1752595647
Reveal Hidden Tumor Complexity with Single-Cell Genomic Profiling
Fiercebiotech.com
1752522623
Is Your Viral Safety Strategy Ready for the Next Regulatory Shift?
Fiercebiotech.com
1752522571
| 07.14.25 | BD, Waters' $17.5B deal creates lab to ol powerhouse; FDA rejects Ultragenyx’s gene therapy
Fiercebiotech.com
1752519857
The First Barrier Isn’t the Last—It’ s Just the Start of the Domino Effect
Fiercebiotech.com
1752516327
E, save your spot for this upcoming webinar?
Fiercebiotech.com
1752513917
| 07.14.25 | AZ's $1.3B CinCor bet scores in hypertension ph. 3; FDA denies Ultragenyx AAV gene therapy
Fiercebiotech.com
1752507802
Don't be the only one at Your Company who misses this webinar - Register now
Fiercebiotech.com
1752335317
| 07.12.25 | Trump signs 'big, beautiful bill'; Judge hits CVS' Omnicare with $949M in penalties
Fiercebiotech.com
1752323568
| 07.11.25 | FDA document drop sheds light on drug refusal process; Agency rejects Capricor DMD cell therapy
Fiercebiotech.com
1752255796
Why top gene therapy manufacturers are rethinking lysis
Fiercebiotech.com
1752254803
© 2025
Information
Terms and Conditions
Privacy
Close
Home
Publishers
Categories
Trending
Inbox
Create Account
Sign in
© 2025
Information
Terms and Conditions
Privacy
Nederlands
Deutsch